SynthesisOncotarget2016

Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.

Tang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.